IOVA vs MTCH · rev $170.7M vs P/E 13, rev $1.72B
Iovance Biotherapeutics Inc (IOVA) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
IOVA currently screens at market cap $1.89B. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the IOVA and MTCH stock pages for the full models.
Not investment advice.